← Open Payments lookup

JOSHUA CLEMMER: Open Payments

NPI 1730775784 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$349 in 18 payments from 8 companies in 2025. Trend: 2023 $669 · 2024 $733 · 2025 $349

Food & beverage: $349
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$77
ABBVIE INC.4$65
Otsuka America Pharmaceutical, Inc.2$44
Janssen Pharmaceuticals, Inc2$44
Neurocrine BioSciences, Inc.2$41
Sage Therapeutics, LLC2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Supernus Pharmaceuticals, Inc.1$17

Products named: COBENFY, VRAYLAR, INVEGA SUSTENNA, INGREZZA, ZURZUVAE, CAPLYTA, REXULTI, ABILIFY MAINTENA.

Industry payments across NV — which companies pay providers there.